cn3
Monday, 10 October 2016
An Extended Trial for Bristol-MyersSquibb
Bristol-Myers Squibb’s disappointing clinical trial results may continue to weigh on the stock.
from WSJ.com: Markets http://ift.tt/2e0FCKK
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment